Detected ·
201 Therapeutics
CHF 150KOther
University of Basel spin-off 201 Therapeutics received CHF 150,000 (Stage III) from Venture Kick to advance targeted liver cancer therapies.
- Website
- —
- linkedin.com/company/113176307
- Amount
- CHF 150 000 CHF
- Stage
- Other
- Event
- Funding round
- Detected
- 2026-11-13 12:10:08 UTC
- Signal ID
- 95184de5-de52-4e6c-ba0f-5d78fc0f82a6
As the API returns it
{
"id": "95184de5-de52-4e6c-ba0f-5d78fc0f82a6",
"created_at": "2026-11-13T12:10:08.980057Z",
"company_name": "201 Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/113176307",
"event_type": "funding",
"funding_amount": 150000,
"funding_currency": "CHF",
"funding_stage": "other",
"message": "*University of Basel spin-off 201 Therapeutics received CHF 150,000 (Stage III) from Venture Kick to advance targeted liver cancer therapies.*"
}